Nomura International
VC Fund
London, United Kingdom
Nomura International is an Asian financial services group engaged in the trading and sale of fixed income and equity products.
- Total investments:
- 15
- Last investment:
- Lead investor:
- 67%
Last updated:
For AI agents: llms.txt
Industries Nomura International invests in
MedicalSoftwareHealth CareBiotechnologyPharmaceutical
Stages Nomura International invests in
Funding RoundSeries CSeries BSeed
Countries Nomura International invests in
United StatesCanadaUnited Kingdom
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Kenji Sugiyama
|
|||
Investment Focus
Industry
- Medical 4 (27%)
- Software 4 (27%)
- Health Care 4 (27%)
- Biotechnology 4 (27%)
- Pharmaceutical 3 (20%)
Stage
- Funding Round 7 (47%)
- Series C 4 (27%)
- Series B 3 (20%)
- Seed 1 (7%)
Country
- United States 11 (73%)
- Canada 2 (13%)
- United Kingdom 1 (7%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Kenji Sugiyama
Head of Merchant Banking EMEA
|
Head of Merchant Banking EMEA | Total investments: 1 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Tevaera
|
Tevaera enhances multi-genre game launch and play using zkStack-based L3 gaming chain, offering multiplayer features and UX-focused apps, facilitating user, liquidity, and builders' free flow within zkNation. | $5M / Seed / Apr 24, 2024 | |
Compellent Technologies
|
Compellent Technologies, Inc. develops and provides enterprise storage software and hardware solutions that automate the movement and management of data. They offers Fluid Data Storage, an enterprise storage platform, Fluid Data Architecture, a network storage solution to manage data at a granular level, and Storage Center 5.4, which allowsenterprises to adapt to changing business requirements. | $15M / Sep 25, 2006 | |
Meriton Networks
|
As of April 4, 2008, Meriton Networks, Inc. was acquired by Xtera Communications, Inc. Meriton Networks, Inc. offers optical networking products. Its products include carrier ethernet transport, an architecture based on wavelength networking; 3300 OSM, an optical services multiplexer; 6400 OTP, an optical transport platform; 5400 OTP, an opticaltransport platform, which provides a multi-service transport solution for network applications that do not require the high drop capacity of the full-featured 6400 OTP; 7200 OSP, an optical switching platform used for consolidating optical transport capabilities within a single network element; and 9500 NPT, a network planning tool that helps in the design and planning of optical networks. The company also offers network management software, amplifiers, and accessories. It also offers technical assistance, hardware replacement, implementation, network health check, training, and network optimization services. The company's products are used in research and education, as well as by telecom service providers, cable operators, and enterprises. It has operations in Canada, the United States, Europe, the Asia Pacific, and Central/Latin America. Meriton Networks, Inc. was formerly known as Edgeflow, Inc. and changed its name to Meriton Networks, Inc. in November 2001. Meriton Networks, Inc. was founded in 2000 and is based in Ottawa, Canada. | $54M / Series C / Jun 27, 2005 | |
Gyre Therapeutics
|
Catalyst Biosciences is a drug discovery and development company. It is creating novel catalytic biopharmaceutical products based on engineered human proteases. The mission is to establish protease therapeutics as a new therapeutic platform comparable in depth and scope to antibody pharmaceuticals. The Company is developing proteases for thetreatment of a broad range of diseases with a strong focus on hemostasis and inflammation. Founded in 1997, the company is headquartered in South San Francisco, California. | $46M / Dec 05, 2002 | |
CyberArk
|
CyberArk is a security company focused on striking targeted cyber threats. It helps companies protect their highest-value information assets, infrastructure, and applications. The company is focused on delivering a new category of targeted security solutions that help clients stop reacting to cyber threats and get ahead of them, preventing attackescalation before irreparable business harm is done.CyberArk was launched by Udi Mokady in 1999 and is based in Newton, Massachusetts with offices in the U.S., Israel, U.K., France, Germany, the Netherlands, and Singapore and serves customers in more than 65 countries. | $15M / Series B / Mar 26, 2002 | |
Pharmion
|
Pharmion is a global biotech company that is dedicated to the hematology and oncology communities. We work in partnership with a network of scientific and clinical advisors to identify and develop products for global hematology and oncology markets. To expand each product's potential, we have established our own regulatory, development andsales and marketing organizations in the United States, Europe, and Australia, and we have developed a third-party distributor network to serve the hematology and oncology markets in 20 additional countries throughout the Middle East, Asia, and Latin America. The global capabilities within our sales, marketing and distribution organization distinguishes us from other companies of a similar size. With our international network we can reach physicians and their patients in more than 30 countries.With proven development and regulatory professionals and an experienced global commercialization team, we concentrate our resources on licensing, developing, and commercializing therapeutic products for the treatment of hematology and oncology patients. Through these efforts, we seek to provide greater therapeutic options to hematologists and oncologists with the ultimate goal of extending survival and improving patients’ quality of life. | $65M / Dec 14, 2001 | |
Altus Pharmaceuticals
|
Altus is an information technology consulting firm with global impact. We are a trusted strategic partner for world-class healthcare providers, global manufacturing companies, top financial institutions, and other leading businesses. | $50.8M / Series B / Oct 03, 2001 | |
ViaCell
|
ViaCell is a biotechnology company focused on the area of women’s health. The company develops ViaCord, which enables families preserve their baby’s umbilical cord blood at the time of birth for possible future medical use; and ViaCyte, to broaden reproductive choices for women through the cryopreservation of human unfertilized eggs.ViaCell isbased in Boston, Massachusetts. | $48M / Nov 14, 2000 | |
ArrayComm
|
ArrayComm LLC provides multi-antenna signal processing software for wireless systems. The company offers software for wireless client devices and infrastructure equipment to improve subscriber experiences and radio network economics through gains in coverage, client data rates, and capacity in base stations, client devices, and MIMO architectures.Its software is implemented on W-CDMA, HSDPA, WiMAX, PHS, GSM, and HC-SDMA networks in Australia, South Africa, China, Taiwan, Japan, the Philippines, Thailand, and the Middle East. | $34M / Sep 06, 2000 | |
Congruency
|
Founded in 1998, congruency, Inc. is a premier provider of hosted IP telcom services and the first company to define and lead the Communications Application Service Provider (CASP) market. A CASP is a new type of ASP that permits Internet-based delivery of a full range of communications services, from voice, to data, to targeted contentpersonalized to IP telephones and Internet appliances.Based in Rochelle Park, NJ with development offices in Petach-Tikva, Israel, congruency has developed a "next generation," true Internet voice networking platform that operates with all broadband access technologies. The system uses an architecture incorporating Voice-over-IP, patent-pending technology, ITU/IETF standards and proprietary methods. The result is high quality, traditional and advanced voice communication services over broadband data networks.The network is designed to work with new Internet telephone appliances such as congruency's own i.Picasso© family of phone appliances -- which allow true IP telephony on the business desktop. These IP appliances have the simplicity, familiarity and feel of traditional telephones, but offer advanced Internet capabilities including the delivery of new and easily-customized communications services. The demand for these devices is expected to grow exponentially. Phillips Infotech predicts that over the next four years, more than 10 million business telephone lines will convert to IP.congruency markets these services to Competitive Local Exchange Carriers (CLECs), Internet Service Providers (ISPs), and Building Local Exchange Carriers (BLECs). Due to rapidly increasing competition within their markets, service providers are being compelled to find ways to enhance their products and services. Most currently, they offer similar low-margin commodity transport services, limiting their revenue-generating opportunities. In addition, service providers suffer from customer churn, due to a market in which all providers sell the same basic services.congruency's Communications Network offers a new world of opportunities for CLECs, ISPs, and BLECs by allowing them to sell a host of new, quality, IP services to their customers, without investing in expensive equipment and resources. Through its advanced services, congruency makes it possible for service providers to easily move from a low-cost transport, or a "free" telephony model to a "value-added services" business model, permitting them to generate new revenue streams. In addition, new "value-added" services permit service providers to build customer loyalty, and significantly reduce customer churn and low-profit margins that now characterize their marketplace.As the leader of CASP, congruency is prepared to meet the future needs of the marketplace for IP voice, data and targeted content. | $10M / Series C / May 24, 2000 | |
| See all 15 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
SaaS Investors
99,274 investors
Software Investors
50,021 investors
Health Care Investors
43,014 investors
Biotech Investors
21,775 investors
Biotechnology Investors
19,370 investors
Medical Investors
18,848 investors
SaaS VC Funds
61,208 investors
Software VC Funds
31,919 investors
Health Care VC Funds
32,370 investors
FAQ
What does Nomura International invest in?
Nomura International invests primarily in Medical, Software and Health Care startups, most often at Funding Round and Series C stage. Most of the 15 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Nomura International?
For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Nomura International?
The team at Nomura International includes Kenji Sugiyama (Head of Merchant Banking EMEA). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
